You searched for Switzerland - Page 9 of 39

crispr therapeutics muscle stem cells anagenesis

News and Trends 10 Jun 2016

CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy

…Dystrophy (DMD). CRISPR Therapeutics (Basel, Switzerland) is the European champion of gene editing for health applications, a field that promises to revolutionize therapies – even if it’s in the middle…

June 10, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 18 Apr 2016

Very promising Results for Resistant Lung Cancer

…using computational and structural biology research. It is based in Cambridge (US) and Lausanne (Switzerland). One of the hard-to-treat cancers that Ariad is targeting is a type of non-small cell…

April 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 15 Aug 2019

Swiss Scientists Upgrade CRISPR to Edit Many Genes at Once

A research group at ETH Zurich, Switzerland, has made it possible to edit hundreds of genes at once with CRISPR gene editing. CRISPR gene editing has revolutionized the biotech industry…

August 15, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 28 Nov 2022

Localizing BRCA gene mutations to better treat ovarian cancer

…cancer experience a recurrence of the disease within five years. An international team led by the University of Geneva (UNIGE) in Switzerland, the Geneva University Hospitals (HUG), the Centre Léon…

November 28, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 20 Jun 2016

Meet the Biotech successfully using Bacteria for Immuno-Oncology

…surprised about how elegant the technology is when I had a chat with the Executive Chairman Klaus Breiner at BioEquity in Copenhagen. Vaximm is based in Basel (Switzerland) and Mannheim…

June 20, 2016 - 4 minutesmins - By Philip Hemme

macular degeneration xbrane helvetic xlucane biosimilar lucentis blindness iran

News and Trends 18 Jan 2016

Where there be Patent-Free Markets: Swiss-Swedish Biosimilar for Blindess Reaches Iran

Helvetic BioPharma (Switzerland) estimates that 70,000 people suffer from age-related macular degeneration in Iran, the leading cause of blindness. This deal with Xbrane in Stockholm (Sweden) will debut a biosimilar…

January 18, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 22 Sep 2022

Study data for glioblastoma treatment confirms safety and tolerability profile

…development and commercialization of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR). Telix Pharmaceuticals is headquartered in Melbourne, Australia, with international operations in Belgium, Japan, Switzerland, and the U.S….

September 22, 2022 - 4 minutesmins - By Liza Laws

Lonza Chr Hansen Microbiome Manufacturing

News and Trends 3 Apr 2019

Joint Venture First to Offer Seamless Manufacturing of Microbiome Therapies

…Basel, Switzerland. The money will be spent on creating medical-grade production facilities for live biotherapeutic products, by upgrading existing facilities in Hørsholm, Denmark and equipping new facilities in Basel. In…

April 3, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 21 Dec 2022

Watch: Aphaia Pharma interview

Aphaia Pharma is a Zug, Switzerland, headquartered clinical-stage biopharmaceutical company. It harnesses proprietary precision-targeted drug delivery technology to restore endogenous hormone release in the gastrointestinal tract to treat and prevent…

December 21, 2022 - 1 minutemin - By Jim Cornall

evolva us navy composite material synbio

News and Trends 14 Apr 2016

European Biotech teams up with US Navy to engineer Military Materials

…near Basel (Switzerland), but with offices and R&D also in Denmark. It has developed its yeast platform to produce high-value chemicals via fermentation. So far, Evolva has developed interesting projects…

April 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

More News! 11 Sep 2017

Could a Protein in Yeast hold the Secret to Escaping Age-Related Diseases?

Researchers in Basel, Switzerland have identified a protein in yeast that slows protein synthesis, prolonging their lifespan. Gcn4 is a transcription factor that regulates the expression around 10% of the…

September 11, 2017 - 2 minutesmins - By Alex Dale

leukemia mesothelioma myeloma sellas cancer immunoncology fda wt1

News and Trends 2 Mar 2016

Swiss Cancer Vaccine Gets 2 FDA Orphan Drug Designations

Sellas (Switzerland) is developing an immunotherapeutic cancer vaccine – which can be easier now that the FDA granted it Orphan Drug designations for two types of cancer (for the lung…

March 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Switzerland

CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy

Very promising Results for Resistant Lung Cancer

Swiss Scientists Upgrade CRISPR to Edit Many Genes at Once

Localizing BRCA gene mutations to better treat ovarian cancer

Meet the Biotech successfully using Bacteria for Immuno-Oncology

Where there be Patent-Free Markets: Swiss-Swedish Biosimilar for Blindess Reaches Iran

Study data for glioblastoma treatment confirms safety and tolerability profile

Joint Venture First to Offer Seamless Manufacturing of Microbiome Therapies

Watch: Aphaia Pharma interview

European Biotech teams up with US Navy to engineer Military Materials

Could a Protein in Yeast hold the Secret to Escaping Age-Related Diseases?

Swiss Cancer Vaccine Gets 2 FDA Orphan Drug Designations

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!